Videos
Winter Solstice 2012 Alignment.mov
 | Video transmission of Energy Body Adjustment (etheric & astral, including causal) in preparation for the Winter Solstice, 2012. Through use of a gesture password, you can link into resonance with the 6 Eco-laser formulas projected into acupuncture points on the Witness that clear, balance and prepare the Energy Bodies for reception of beneficial Cosmic Forces streaming onto the Earth during the Winter's Solstice. I am using Spiritual Science; technology linked with Spirit and Science, (& corrected for EMF!) to offer this gift to those with whom I have worked in the past and also to extend this alignment to others who resonate with the principles contained within this protocol. | Views: 53  0 ratings |
| Time: 12:39 | More in Education |
Google Videos - far infrared therapy
Video provided by www.promolife.com. This video demonstrates the effects of far infrared. For more information on FIR and for FIR products, visit ...
HubMed - Cupping Therapy
Safety of Cupping During Bevacizumab Therapy.
J Altern Complement Med. 2013 Feb 4;
Klempner SJ, Costa DB, Wu PA, Ariyabuddhiphongs KD
Abstract Objectives: This study reports on the safety of the complementary and alternative medicine (CAM) practice of cupping in a patient undergoing concomitant therapy with bevacizumab for advanced non-small-cell lung cancer (NSCLC), and raises awareness of the need for improved communication between CAM practitioners and oncologists during the care of patients with cancer. The practice of cupping generates local hyperemia, disrupts superficial vasculature in the dermis, and leads to cutaneous lesions including circular erythema, edema, and subsequently ecchymosis. There are no data on the safety of cupping in patients being treated with bevacizumab. Design: This is a single-institution case report. Settings/location: The setting for this study was a tertiary-care academic medical center. Conclusions: A patient with advanced NSCLC received four cycles of carboplatin AUC 6, paclitaxel 200 mg/m(2), and bevacizumab 15 mg/kg, and was continued on every-3-week maintenance bevacizumab 15 mg/kg. The patient underwent glass dry cupping during cycle six of maintenance bevacizumab treatment without overt cutaneous adverse events or bleeding. The patient did not realize he should have communicated his cupping plans or recent bevacizumab treatment with his providers.
Google Videos - Low Level Laser therapy
News brodcast of the Erchoina Laser being used for foot pain.
No comments:
Post a Comment